#CCC19

@mtmdphd.bsky.social

9 months ago

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium Patients with cancer may be at high risk of adverse outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of patients with cancer and coronavirus 2...

Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer

1 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

9 months ago

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

0 1 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer [Mar 28, 2022] Fu et al. @DrDimpyShah @COVID19nCCC @JAMANetworkOpen ow.ly/qvGM50Iu5VT #NCT04354701 #cancerdisparities #CCC19 #COVID19nCancer #COVID19

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19 [Nov 3, 2022] @ZiadBakouny et al. @DrChoueiri @TMWiseDraper @COVID19nCCC @JAMAOnc jamanetwork.com/journals/jam... #COVID19nCancer #CCC19 #IDonc #ImmunoOnc #NCT04354701

2 1 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] @ADesaiMD @DrTJM_MD et al. @JAMAOnc ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 @COVID19nCCC

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

COVID-19 vaccination and breakthrough infections in patients with cancer Vaccination is an important preventive health measure to protect against symptomatic and severe COVID-19. Impaired immunity secondary to an underlying malignancy or recent receipt of antineoplastic systemic therapies can result in less robust antibody titers following vaccination and possible risk of breakthrough infection. As clinical trials evaluating COVID-19 vaccines largely excluded patients with a history of cancer and those on active immunosuppression (including chemotherapy), limited evidence is available to inform the clinical efficacy of COVID-19 vaccination across the spectrum of patients with cancer.

COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer [Dec 24, 2021] @dr_aschmidt et al. @DrChoueiri @COVID19nCCC @Annals_Oncology ow.ly/tB9F50HiP4q #COVID19 #COVID19Vaccine #CCC19 #COVID19nCancer #IDonc

1 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] @ADesaiMD @hemoncwarner @NicoleKuderer @mtmdphd @corrie_painter @gary_lyman @GlopesMd @NatureCancer ow.ly/wuyD30qzDyS #CCC19 #COVID19nCANCER @COVID19nCCC

0 0 0 0

Jeremy Warner, MD, MS, FAMIA, FASCO

@hemoncwarner.bsky.social

1 year ago

ScienceDirect.com | Science, health and medical journals, full text articles and books.

Check out our new article, "Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: An international cohort study in cancer patients with SARS-CoV-2 infection". Open access link: authors.elsevier.com/sd/article/S... #CCC19

2 1 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer [Dec 24, 2021] @dr_aschmidt et al. @DrChoueiri @COVID19nCCC @Annals_Oncology ow.ly/tB9F50HiP4q #COVID19 #COVID19Vaccine #CCC19 #COVID19nCancer #IDonc

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Crowdsourcing a crisis response for COVID-19 in oncology - Nature Cancer Crowdsourcing efforts are currently underway to collect and analyze data from patients with cancer who are affected by the COVID-19 pandemic. These community-led initiatives will fill key knowledge ga...

Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] @ADesaiMD @hemoncwarner @NicoleKuderer @mtmdphd @corrie_painter @gary_lyman @GlopesMd @NatureCancer ow.ly/wuyD30qzDyS #CCC19 #COVID19nCANCER @COVID19nCCC

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

twitter.com/DrMJoyner/st... #COVID19CP #CCC19 #COVID19nCancer cc @DrJPHenderson @hemoncwarner.bsky.social @equis @pgrivasmdphd.bsky.social

1 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Time-Related Biases in Nonrandomized COVID-19–Era Studies Using Real-world Data [Jun 17, 2021] @gregcalip @RMiksad Sarkar @JAMAOnc ow.ly/wTHl50FcSHZ #COVID19CP #COVID19nCancer #COVID19 #CCC19 @COVID19nCCC ...real-world data should continue to play a crucial role...

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc

1 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer [Dec 10, 2021] @ArielleElkrief et al. @hemoncwarner @COVID19nCCC @CD_AACR ow.ly/2mkh50H8AUG #COVID19nCancer #CCC19

3 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19 [Jul 14, 2021] @AngLi_MD et al. @RosovskyRachel @COVID19nCCC @JTHjournal
onlinelibrary.wiley.com/doi/10.1111/... #VTE #2019nCoV #COVID19 #CCC19

1 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study Patients with metastatic cancer have more severe outcomes than patients without metastasis, with those with metastasis to the brain having the highest odds of severe COVID-19. When adjusting for init....

The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study [Feb 20, 2024] @ClCastellano et al. @JournalCancer
acsjournals.onlinelibrary.wiley.com/doi/10.1002/... #CCC19 #COVID19nCancer #COVID19 @COVID19nCCC #camets

2 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer [Mar 28, 2022] Fu et al. @DrDimpyShah @COVID19nCCC @JAMANetworkOpen ow.ly/qvGM50Iu5VT #NCT04354701 #cancerdisparities #CCC19 #COVID19nCancer #COVID19

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

4 0 1 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

4 0 0 0

Wayne Liang, MD | Pediatric Hematology Oncology BMT Informatics

@wayneliangmd.bsky.social

1 year ago

Great to see HemOnc.org collaborator @ecquis.bsky.social recognized for excellent science 🧪 communication related to #CCC19 #Covid research in #Cancer!

He is the recipient of Eric & Wendy Schmidt Award for Excellence in Science Communications

#scicomm @hemonc.bsky.social @hemoncwarner.bsky.social

4 1 1 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

From a Tweet to The Lancet in 10 Weeks: COVID-Cancer Consortium The COVID-19 and Cancer Consortium started with a single tweet. Ten weeks later, it had recruited 317 collaborators and 110 global institutions, accrued data from 2300 patients, and had published in t...

From a Tweet to The Lancet in 10 Weeks: COVID-Cancer Consortium [June 17, 2020] @leask_helen @MedscapeOnc ow.ly/RJTr30qS9pf #CCC19 #COVID19 #COVDI19nCancer @COVID19nCCC

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Crowdsourcing a crisis response for COVID-19 in oncology - Nature Cancer Crowdsourcing efforts are currently underway to collect and analyze data from patients with cancer who are affected by the COVID-19 pandemic. These community-led initiatives will fill key knowledge ga...

Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] @ADesaiMD @hemoncwarner @NicoleKuderer @mtmdphd @corrie_painter @gary_lyman @GlopesMd @NatureCancer ow.ly/wuyD30qzDyS #CCC19 #COVID19nCANCER @COVID19nCCC

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

COVID-19 and Cancer—A Review of the Registry-Based Pandemic Response This review describes the registry efforts made during the COVID-19 pandemic with the aim of investigating and sharing information about the history, risk factors, and outcomes of patients with COVID-...

COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] @ADesaiMD @DrTJM_MD et al. @JAMAOnc ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 @COVID19nCCC

0 0 0 0

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

1 year ago

Five Questions With: Sanjay Mishra Sanjay Mishra, research program manager at the Lifespan Cancer Institute, recently received the Eric and Wendy Schmidt Award for Excellence in Science Communications from the National Academies of Sci...

Five Questions With: Sanjay Mishra @Ecquis [Nov 26, 2023] By @Katie_c912 @ProvBusNews
pbn.com/five-questio... #CCC19 @COVID19nCCC #COVID19nCancer #COVID19Vaccine @DrDonnaRivera @NCIJBSloan

3 0 0 1

Posts tagged #CCC19